Sildenafil/testosterone - Emotional Brain

Drug Profile

Sildenafil/testosterone - Emotional Brain

Alternative Names: Lybrido; Testosterone/sildenafil

Latest Information Update: 05 Jan 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Emotional Brain
  • Developer Companion Diagnostics BV; Emotional Brain
  • Class Anabolic steroids; Androstenols; Hormonal replacements; Phenyl ethers; Piperazines; Purines; Small molecules; Sulfones; Testosterone congeners
  • Mechanism of Action Androgen receptor agonists; Testosterone replacements; Type 5 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Female sexual dysfunction

Most Recent Events

  • 05 Jan 2016 A phase III trial for Female sexual dysfunction is still being planned in USA and Europe
  • 20 Apr 2015 Sildenafil/testosterone has patent protection in USA, Europe, China, Australia, Mexico and Hong Kong
  • 20 Apr 2015 Emotional Brain plans a phase III trial for Female sexual dysfunction in USA and Europe
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top